Endometriosis

In a recent pilot trial, endometriosis-related visual-analog scale and quality-of-life scores were improved during anakinra treatment cycles vs placebo cycles.

A recent study suggests that postoperative endometriosis patients experience improved quality of life through hormone therapies guided by optimizing treatment based on individual hormonal receptor profiles.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Women with ovarian endometriomas or deep infiltrating endometriosis face a significantly higher risk of ovarian cancer, highlighting the need for increased awareness and research into these associations.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Serac Healthcare’s 99mTc-maraciclatide, a new radio-labelled tracer, gains FDA Fast Track Designation for its potential to improve non-invasive diagnosis of superficial peritoneal endometriosis in patients aged 16 and older.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study revealed that women with endometriosis are significantly more likely to develop mental health issues, including depression and anxiety.

Experts recommend early referral to specialized centers for adolescents with dysmenorrhea to ensure timely diagnosis and treatment of potential endometriosis, preventing disease progression and preserving fertility.

A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.

A recent study unveiled the sustained safety and efficacy of relugolix combination therapy over 2 years.

A recent study revealed that women with endometriosis not only face a mean delay of 7 to 11 years in diagnosis but also suffer from increased menstrual, mental health, and other pain symptoms, impacting their overall well-being and quality of life.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Findings and significance for gynecologic surgeons.

In a recent study, women with a history of dysmenorrhea were at a significantly increased risk of endometriosis.

In a recent study, a lower pain-related quality of life was found in patients with preoperative pelvic pain conditions after surgery.

In a recent study, providers were more likely to recommend combined hormone replacement therapy (HRT) than estrogen-only HRT in patients with severe endometriosis because of recurrence risks from estrogen-only HRT.

Reductions in symptom incidence and severity from uterine fibroids and endometriosis have been observed in patients receiving relugolix combination therapy.

In a recent study, the Deep Pelvic Endometriosis Index accurately predicted operating and hospital stay length, along with postoperative complications, in patients with deep pelvic endometriosis.

Pain mechanisms are multifactorial, complex, and still poorly understood.

A panel of experts provide an overview of choosing endometriosis treatment and how to discuss these options with patients.

A panel of experts provide an overview of GnRH antagonists trial data for the treatment of endometriosis.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the multidisciplinary approach and shared decision-making strategies associated with endometriosis treatment.

Hugh Taylor, MD, along with a panel of experts, discuss the different challenges of diagnosing endometriosis as well as explaining why there is commonly a delay in diagnosis.

A panel of experts provide an overview of the health complications that are associated with endometriosis.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the 3 main types of endometriosis and the commonly associated symptoms and risk factors.

Hugh Taylor, MD, leads a discussion with a panel of experts about the prevalence of endometriosis.

Researchers from the Feinstein Institute in Manhasset, New York, found single-cell RNA sequencing to be an effective and noninvasive way to screen for and diagnose patients with endometriosis.

Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

Women with endometriosis had a 34% greater risk of stroke than women without the chronic inflammatory gynecological condition, according to an analysis of the Nurses Health Study II.